Introduction
HCM diagnosis by echocardiography
Echocardiographic parameter | Cutoff values suggesting HCM | |
---|---|---|
Hypertrophy | Wall thickness / IVS to PW ratio | > 15 mma, > 1.3b |
Distribution of hypertrophy | Asymmetric hypertrophy RV free wall hypertrophy ≥ 7 mmc Reverse hypertrophic IVS | |
Mitral valve apparatus | Anterior leaflet elongation | AML > 30 mm (17 mm/m2) |
Posterior leaflet elongation | Absolute height of PL > 15 mm | |
Papillary muscle abnormalities | Anterior displacement of AL PM | |
Aorto-mitral angle | < 120° | |
Mitral chordae | Elongation/thickening/buckling | |
SAM | > 30% systolic contact with IVS | |
Systolic function | Systolic longitudinal dysfunction | Lateral S (TDI) < 4 cm/s Worse GLS (> − 10.6%)d Paradoxical apical strain (apical HCM) |
Normal/supranormal radial strain | ||
Diastolic functione | Impaired relaxation | Lateral e’ < 4 cm/s |
Elevated filling pressures | Increase of A wave velocity during Valsalva maneuvere LAVI > 34 mL/m2 f Ar-A ≥ 30 ms E/e’ ratio > 10g PAPs > 35 mmHg | |
Intraventricular obstruction | LVOT gradient /Midventricular obstruction | > 30 mmHg “Dagger shaped”/“Lobster claw” Doppler envelope |
Other echocardiographic findings supporting the diagnosis of HCM
Mitral valve apparatus abnormalities
Left ventricular systolic function
Left ventricular diastolic function
Intraventricular obstruction in HCM
Subclinical hypertrophic cardiomyopathy
Advanced echocardiographic techniques
Condition | Specific features (vs. HCM) |
---|---|
Athlete’s heart | Normal/slightly increased LV volumes |
Normal/mildly dilated LA | |
Normal/supranormal annular systolic and diastolic velocities by TDI | |
Normal GLS | |
Reversible hypertrophy | |
Hypertensive heart disease | Symmetric hypertrophya |
End-systolic SAM | |
Mild to moderate systolic longitudinal dysfunction: better GLS (< − 10.6%) | |
Reduced systolic radial strain | |
Cardiac amyloidosis | Concentric, biventricular hypertrophy |
Thickening of the interatrial septum/cardiac valves | |
Hyperechoic walls (“speckled” appearance) | |
Pericardial effusion | |
Significantly decreased longitudinal strain/strain rate, with “apical sparing” | |
Fabry disease | Concentric, biventricular hypertrophy |
Thickening of the PM/cardiac valves | |
Lateral LV wall is most often affected (reduced longitudinal strain) | |
Circumferential strain is normal | |
Valvular/subvalvular obstruction | Concentric LV hypertrophy |
Valve calcifications/restricted leaflet mobility (valvular obstruction) | |
Fibrous membrane/ring, discrete ridges or diffuse LVOT narrowing (subvalvular obstruction) | |
Fixed LVOT obstruction with no SAM |
Prognostic stratification in patients with HCM
Echocardiographic parameter | Value | Prognostic implication |
---|---|---|
Maximal WT | ≥ 30 mm | 3 × higher risk for VAs |
LVOT obstruction | ≥ 30 mmHg at rest, ≥ 50 mmHg (provoked) | Increased risk of SCD (1.5% vs. 0.9% per year) |
Increased risk of HF/HF progressiona | ||
Increased risk of stroke | ||
LA diameter | > 45 mm | Increased risk of SCD |
Increased risk of AF/AF recurrence | ||
Increased risk of stroke | ||
LA volumeb | ≥ 37 mL/m2 | Increased risk of AF |
LA systolic strainb | ≤ 23.4% | Increased risk of AF |
HF symptoms | ||
Apical aneurysm | [≥ 4 cm]c | Increased risk of SCD (due to VAs and thrombus embolization) |
RV hypertrophy | ≥ 7 mm | Increased risk of VAs (NSVT) |
Increased risk of HF symptoms | ||
Abnormal GLS | ≥ − 16% | Increased risk of VAs |
Increased risk of HF/HF hospitalization/cardiac death | ||
Systolic annular lateral wall velocity (S) | < 4 cm/s | Increased risk of HF/HF hospitalization |
Increased risk of cardiac death | ||
Elevated filling pressures | E/e′ > 10, Ar-A ≥ 30 ms | Increased risk of HF/HF worsening |
Mechanical dispersion | ≥ 64 ± 22 ms | Increased risk of NSVT |
Correlates with fibrosis (LGE) at CMR |